Related references
Note: Only part of the references are listed.Effects of Benzalkonium Chloride-Preserved, Polyquad-Preserved, and sofZia-Preserved Topical Glaucoma Medications on Human Ocular Epithelial Cells
David A. Ammar et al.
ADVANCES IN THERAPY (2010)
Allergic contact dermatitis due to the beta-blocker betaxolol in eyedrops, with cross-sensitivity to timolol
Massimiliano Nino et al.
CONTACT DERMATITIS (2010)
Effects of switching to SofZia-preserved travoprost in patients who presented with superficial punctate keratopathy while under treatment with latanoprost
Sei Yamazaki et al.
JAPANESE JOURNAL OF OPHTHALMOLOGY (2010)
ECZEMA OF THE EYELIDS CAUSED BY PILOCARPINE
Åke Holmberg
ACTA OPHTHALMOLOGICA (2009)
The effects of combination glaucoma medications on ocular surface epithelial cells
David A. Ammar et al.
ADVANCES IN THERAPY (2009)
Antimicrobial efficacy assessment of multi-use solution to disinfect hydrophilic contact lens, in vitro
Aline Cristina Fioravanti Lui et al.
ARQUIVOS BRASILEIROS DE OFTALMOLOGIA (2009)
Extensive facial skin pigmentation after latanoprost treatment
Ke-Hung Chien et al.
CUTANEOUS AND OCULAR TOXICOLOGY (2009)
Allergic Contact Dermatitis eyelid unilateral Iopimax
M. T. Bordel-Gomez et al.
ACTAS DERMO-SIFILIOGRAFICAS (2009)
Topical glaucoma therapy as a risk factor for nasolacrimal duct obstruction
Nir Seider et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
Contact dermatitis caused by latanoprost-containing eye drops with good tolerance to bimatoprost eye drops
Eva Perez-Rodriguez et al.
CONTACT DERMATITIS (2008)
Systemic contact dermatitis to dorzolamide eye drops
Nicolas Kluger et al.
CONTACT DERMATITIS (2008)
Erythema multiforme after use of topical dorzolamide
Vineeta Munshi et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2008)
Reversible cicatricial ectropion precipitated by topical brimonidine eye drops
Petros Aristodemou et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2008)
Topical antiglaucoma medications and lacrimal drainage system obstruction
Mohsen Bahmani Kashkoull et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2008)
Effect of dorzolamide hydrochloride on central corneal thickness in humans with cornea guttata
Matthias G. Wirtitsch et al.
ARCHIVES OF OPHTHALMOLOGY (2007)
Effects of Beta-adrenergic antagonist on width of nasolacrimal drainage system lumen
Junji Narioka et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2007)
Drug-induced ectropion - What is best practice?
Vijay Hegde et al.
OPHTHALMOLOGY (2007)
Travoprost Z ophthalmic solution with sofZia: clinical safety and efficacy
Malik Y. d Kahook
EXPERT REVIEW OF OPHTHALMOLOGY (2007)
The safety and intraocular pressure-lowering efficacy of brimonidine tartrate 0.15% preserved with polyquaternium-1
Jess T. Whitson et al.
OPHTHALMOLOGY (2006)
Allergic contact dermatitis due to beta-blockers in eye drops: a retrospective analysis of multicentre surveillance data 1993-2004
Uta Jappe et al.
ACTA DERMATO-VENEREOLOGICA (2006)
Corneal edema in glaucoma patients after the addition of brinzolamide 1% ophthalmic suspension
H Tanimura et al.
JAPANESE JOURNAL OF OPHTHALMOLOGY (2005)
Brinzolamide induced reversible corneal decompensation
JC Zhao et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2005)
An unusual appearance of limbal conjunctival follicles in a patient on brimonidine and dorzolamide
R Gupta et al.
EYE (2005)
Alphagan allergy may increase the propensity for multiple eye-drop allergy
SA Osborne et al.
EYE (2005)
Interleukin-1 beta tear concentration in glaucomatous and ocular hypertensive patients treated with preservative-free nonselective beta-blockers
G Manni et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2005)
Corneal epithelial cellular dysfunction from benzalkonium chloride (BAC) in vitro
SH Cha et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2004)
An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma
DS Friedman et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2004)
Low incidence of iris pigmentation and eyelash changes in 2 randomized clinical trials with unoprostone isopropyl 0.15%
BE McCarey et al.
OPHTHALMOLOGY (2004)
Endothelial changes associated with topical dorzolamide do appear to be significant
RJ Epstein et al.
ARCHIVES OF OPHTHALMOLOGY (2004)
Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study
PJ Pisella et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2004)
Effects of topical antiglaucoma drugs on apoptosis rates of conjunctival epithelial cells in glaucoma patients
AL Dogan et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2004)
Ocular factors relevant to anti-glaucomatous eyedrop-related keratoepitheliopathy
K Inoue et al.
JOURNAL OF GLAUCOMA (2003)
Comparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chloride
T Ishibashi et al.
JOURNAL OF GLAUCOMA (2003)
Dermatological side effects of brimonidine: A report of three cases
PK Sodhi et al.
JOURNAL OF DERMATOLOGY (2003)
Aspects of the antimicrobial mechanisms of action of a polyquaternium and an amidoamine
CE Codling et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Latanoprost stimulates secretion of matrix metalloproteinases in tenon fibroblasts both in vitro and in vivo
H Mietz et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
Comparison of the effects of topical levobunolol and timolol solution on the human ocular surface
T Ishibashi et al.
CORNEA (2003)
Pilocarpine permeability across ocular tissues and cell cultures: Influence of formulation parameters
M Scholz et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2002)
Mechanism and clinical significance of prostaglandin-induced iris pigmentation
JW Stjernschantz et al.
SURVEY OF OPHTHALMOLOGY (2002)
Putative side effects of prostaglandin analogs
RA Schumer et al.
SURVEY OF OPHTHALMOLOGY (2002)
Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication
PJ Pisella et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2002)
Twelve-month evaluation of brimonidine-purite versus brimonidine in patients with glaucoma or ocular hypertension
LJ Katz
JOURNAL OF GLAUCOMA (2002)
Periorbital dermatitis as a side effect of topical dorzolamide
YM Delaney et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2002)
Reactivation of herpes simplex virus keratitis after initiating bimatoprost treatment for glaucoma
DM Kroll et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2002)
Corneal toxicity secondary to inadvertent use of benzalkonium chloride preserved viscoelastic material in cataract surgery
H Eleftheriadis et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2002)
Allergic contact dermatitis from apraclonidine in eyedrops
JF Silvestre et al.
CONTACT DERMATITIS (2001)
Allergic contact blepharoconjunctivitis from dorzolamide
G Mancuso et al.
CONTACT DERMATITIS (2001)
Effects of common ophthalmic preservatives on ocular health
R Noecker
ADVANCES IN THERAPY (2001)
Intermittent blurred vision and trichomegaly due to latanoprost
TL Woo et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2001)
Allergic contact dermatitis due to dorzolamide eyedrops
M Shimada et al.
CONTACT DERMATITIS (2001)
Herpes simplex virus dermatitis in patients using latanoprost
J Morales et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2001)
The conjunctival epithelium in dry eye subtypes: Effect of preserved and non-preserved topical treatments
JM Albietz et al.
CURRENT EYE RESEARCH (2001)
Changes in ocular surface caused by antiglaucomatous eyedrops:: prospective, randomised study for the comparison of 0.5% timolol v 0.12% unoprostone
J Shimazaki et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2000)
Patients' acceptance of a switch from dorzolamide to brinzolamide for the treatment of glaucoma in a clinical practice setting
H Barnebey et al.
CLINICAL THERAPEUTICS (2000)
Increased eyelid pigmentation associated with use of latanoprost
MS Kook et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2000)
Effect of beta-blocker eyedrops on corneal epithelial barrier function
A Niiya et al.
OPHTHALMOLOGICA (2000)
Share Paper
